Bliss GVS Pharma P/B Ratio
Bliss GVS Pharma (BLISSGVS) P/B ratio is 6.15 (High), book value per share ₹1120.00 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read BLISSGVS dividend yield for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BLISSGVS P/B Ratio — Valuation Insights & Book Value Analysis
Bliss GVS Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 6.15 (High). Explore BLISSGVS investment value to estimate fundamental worth using multiple valuation models.
- Stock appears overvalued with PB of 6.15, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 2856.7% above historical average
- Trading at premium to sector average PB of -0.01
Bliss GVS Pharma P/B Ratio Historical Trend
BLISSGVS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Bliss GVS Pharma screener.
BLISSGVS Historical P/B Ratio — Book Value Per Share & Year-End Price
Bliss GVS Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.47 | ₹1120.0 | ₹523.55 | ₹1,232 | Low |
| 2025 | 0.16 | ₹992.73 | ₹163.39 | ₹1,092 | Low |
| 2024 | 0.18 | ₹911.82 | ₹164.71 | ₹1,003 | Low |
| 2023 | 0.14 | ₹917.0 | ₹124.65 | ₹917 | Low |
| 2022 | 0.09 | ₹847.0 | ₹72.40 | ₹847 | Low |
BLISSGVS vs Healthcare Peers — P/B Ratio Comparison
Bliss GVS Pharma P/B 6.15 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |